| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |